近十年中医药治疗非酒精性脂肪性肝病的临床试验研究综述
A Review of the Clinical Trials of Traditional Chinese Medicine in the Treatment of Nonalcoholic Fatty Liver Disease in Recent Ten Years
DOI: 10.12677/TCM.2019.84042, PDF,  被引量    科研立项经费支持
作者: 沈 楠：上海中医药大学附属龙华医院，脾胃病科，上海；上海中医药大学脾胃病研究所，上海；喻 晓, 潘洁露, 张海燕, 邢练军：上海中医药大学附属龙华医院，脾胃病科，上海
关键词: 中医药；脂肪肝；非酒精性脂肪性肝病；治疗；随机对照试验；Traditional Chinese Medicine； Fatty Liver Disease； Non-Alcoholic Fatty Liver Disease； Treatment； Randomized Controlled Trials
摘要: 近年来，中医药防治非酒精性脂肪性肝病(non-alcohol fatty liver disease, NAFLD)因疗效显著而越来越受到重视，本文通过对近十年的临床随机对照实验进行系统的检索，来评价中医药治疗NAFLD的有效性和安全性。2009年1月至2019年2月，运用CNKI、万方数据库、Pubmed等相关数据库进行检索临床随机对照实验包括单独比较中药制剂或与熊去氧胆酸、水飞蓟、胰岛素增敏剂、降脂药物、抗氧化剂或多烯磷脂酰胆碱联合应用的实验研究，对中医药治疗NAFLD作一综述。
Abstract: In recent years, the prevention and treatment of non-alcoholic fatty liver disease (NAFLD) by traditional Chinese medicine has been paid more and more attention due to its significant efficacy. This paper evaluated the efficacy and safety of traditional Chinese medicine in NAFLD treatment by systematic retrieval of clinical randomized controlled trials conducted in the past decade. Studies were searched on CNKI, Wanfang Data and PubMed from January 2009 to February 2019. RCTs comparing either TCM formulations alone or in combination with ursodeoxycholic acid, Silybum marianum, insulin sensitizers, lipid-lowering drugs, antioxidants or polyene phosphatidylcholine were included, to review the treatment of NAFLD with traditional Chinese medicine.
文章引用：沈楠, 喻晓, 潘洁露, 张海燕, 邢练军. 近十年中医药治疗非酒精性脂肪性肝病的临床试验研究综述[J]. 中医学, 2019, 8(4): 247-253. https://doi.org/10.12677/TCM.2019.84042

参考文献

[1] Araãjo, A.R., Rosso, N., Tiribelli, C., Bellentani, S. and Bedogni, G. (2018) Global Epidemiology of Non-Alcoholic Fatty Liver Disease/Non-Alcoholic Steatohepatitis: What We Need in the Future. Liver International, 38, 47-51. [Google Scholar] [CrossRef] [PubMed]
[2] Fan, J.G. and Farrell, G.C. (2009) Epidemiology of Non-Alcoholic Fatty Liver Disease in China. Journal of Hepatology, 50, 204-210. [Google Scholar] [CrossRef] [PubMed]
[3] Williams, C.D., Stengel, J. and Asike, M.I. (2011) Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy :a prospective study. Gastroenterology, 140, 124-131.
[4] David, K., Kowdley, K.V., Unalp, A., Kanwal, F., Brunt, E.M. and Schwimmer, J.B. (2009) Quality of Life in Adults with nonalcoholic Fatty Liver Disease: Baseline Data from the Nonalcoholic Steatohepatitis Clinical Research NETWORK. Hepatology, 49, 1904-1912. [Google Scholar] [CrossRef] [PubMed]
[5] Ekstedt, M., Franzén, L.E., et al. (2006) Long-Term Fol-low-Up of Patients with NAFLD and Elevated Liver Enzymes. Hepatology, 44, 865-873. [Google Scholar] [CrossRef] [PubMed]
[6] Day, C. (2005) Natural History of NAFLD: Remarkably Benign in the Absence of Cirrhosis. Gastroenterology, 129, 375-378. [Google Scholar] [CrossRef] [PubMed]
[7] 储建坤, 霍晓辉, 马金城. 非酒精性脂肪肝中医症候分布特点及其相关Logistic因素分析[J]. 中华中医药杂志, 2013, 28(6): 1917-1919.
[8] 徐亮, 宓余强, 李萍. 非酒精性脂肪肝中医证型客观化研究[J]. 中华中医药杂志, 2015, 30(7): 2544-2547.
[9] 韩莉, 王观龙, 杨钦河. 数据挖掘非酒精性脂肪性肝病中医证候及用药特点[J]. 北京中医药大学学报, 2015, 38(7): 496-500.
[10] 张慧芹, 郝钰, 李健. 文本挖掘非酒精性脂肪性肝病中医证候及用药规律[J]. 中国中医基础医学杂志, 2014, 20(8): 1120-1122.
[11] 郁强, 张声生, 周滔. 调肝理脾方治疗非酒精性脂肪性肝病肝郁脾虚证的随机对照研究[J]. 中国中西医结合杂志, 2015, 35(4): 401-405.
[12] 程井军. 脂炎消煎剂联合熊去氧胆酸治疗脂肪肝50例的临床研究[C]//中国中西医结合学会肝病专业委员会. 第二十一次全国中西医结合肝病学术会议论文汇编. 北京: 中国中西医结合学会肝病专业委员会, 2012: 2.
[13] 周云, 张敏丽, 杨百京. 小柴胡汤联合熊去氧胆酸胶囊治疗非酒精性脂肪肝临床观察[J]. 内蒙古中医药, 2012, 31(22): 15-16.
[14] 乔成安. 逍遥散加减治疗非酒精性脂肪肝30例[J]. 陕西中医, 2010, 31(9): 1118-1119.
[15] 范国田, 袁建平, 李玲. 降脂保肝汤治疗非酒精性脂肪肝80例[J]. 中国中医药现代远程教育, 2010, 8(8): 51-52.
[16] 鲁琳, 王青. 水飞蓟宾联合中药治疗非酒精性脂肪肝24例疗效观察[J]. 内蒙古中医药, 2017, 36(6): 27.
[17] 刘秀林, 付京云, 刘丽花. 柴荷化痰活血方治疗非酒精性脂肪肝50例临床疗效观察[J]. 北京中医药, 2015, 34(7): 560-562.
[18] 席奇, 刘亚珠, 宋春荣. 疏肝健脾活血方联合水飞蓟宾胶囊治疗非酒精性脂肪肝疗效观察[J]. 陕西中医, 2015(5): 520-522.
[19] 蔡岳, 张赤志, 王学书. 行气化痰法治疗非酒精性脂肪肝的临床观察[J]. 中医药导报, 2015, 21(17): 83-85.
[20] 吴凌康, 史亮亮, 宋希玲. 益气养阴活血中药治疗2型糖尿病合并脂肪肝46例临床观察[J]. 中医杂志, 2011, 52(9): 751-754.
[21] 徐中菊, 王慧, 顾婷婷, 陈宝瑾, 陈雄白. 丹芍疏肝颗粒对不同中医证型非酒精性脂肪肝临床疗效研究[J]. 辽宁中医杂志, 2016, 43(4): 771-773.
[22] 朱平生, 王宇亮, 彭成. 脂消胶囊治疗非酒精性脂肪肝50例疗效观察[J]. 新中医, 2006, 38(4): 31-32.
[23] 胡苏妹. 疏肝健脾化痰法治疗非酒精性脂肪肝40例[J]. 浙江中医杂志, 2008, 43(4): 209.
[24] 彭雪萍.自拟健脾化瘀汤配合他汀类药物治疗非酒精性脂肪肝30例临床观察[J]. 云南中医中药杂志, 2018, 39(3): 53-54.
[25] 武煦峰, 薛博瑜. 益肾运脾汤联合易善复胶囊治疗非酒精性脂肪肝临床研究[J]. 中医学报, 2011, 26(12): 1489-1491.
[26] 牛少强, 户玉轩, 石燕萍. 自拟健脾化湿汤联合多烯磷脂酰胆碱胶囊治疗非酒精性脂肪肝41例疗效观察[J]. 云南中医中药杂志, 2014, 35(1): 37-39.
[27] 李达芬, 白行官, 韦安暄. 消痰降脂方联合多烯磷脂酰胆碱治疗非酒精性脂肪肝的临床观察[J]. 中医药导报, 2010, 16(9): 48-50.
[28] Chris, E., Anstee, Q.M., Teresa, A.L.M., et al. (2018) Modeling NAFLD Disease Burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the Period 2016-2030. Journal of Hepatology, 69, 896-904. [Google Scholar] [CrossRef] [PubMed]